MARSHALL WACE, LLP

Position in LRMR — Larimar Therapeutics, Inc.

CIK 1318757 LONDON, X0

Position in LRMR

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$4,200,587

+$3,773,712 QoQ

Shares Held

933,464

+746.3% QoQ

Ownership

0.899%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2021

10 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Mar 31, 2026

MARSHALL WACE, LLP holds $2,766,756,129 across 280 Biotechnology names. LRMR ranks #109 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	1,099,318	$363,731,344
2	VRTX	Vertex Pharmaceuticals Inc / Ma	317,058	$141,579,078
3	INCY	Incyte Corp	1,253,138	$117,945,347
4	RPRX	Royalty Pharma plc	2,120,692	$101,729,594
5	RCUS	Arcus Biosciences, Inc.	3,761,437	$81,247,039
6	PTGX	Protagonist Therapeutics, Inc	628,075	$66,199,104
7	ROIV	Roivant Sciences Ltd.	2,246,943	$62,240,320
8	COGT	Cogent Biosciences, Inc.	1,600,168	$61,590,466

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$4,200,587	933,464	+746.3%	Shares	Other	2026-05-15
2024-12-31	$426,875	110,304	+52.2%	Shares	Other	2025-02-13
2024-09-30	$474,835	72,494	-23.9%	Shares	Other	2024-11-14
2024-06-30	$690,301	95,214	-4.6%	Shares	Other	2024-08-14
2024-03-31	$757,390	99,788	+69.4%	Shares	Other	2024-05-15
2023-03-31	$266,853	58,908	+52.2%	Shares	Other	2023-05-15
2022-09-30	$123,872	38,710	+239.8%	Shares	Other	2022-11-14
2021-12-31	$122,919	11,392	-57.2%	Shares	Other	2022-02-14
2021-09-30	$306,548	26,587	-50.9%	Shares	Sole	2021-11-15
2021-03-31	$790,605	54,114	—	Shares	Sole	2021-05-17
No filing history on record for this holder in this stock.